AXDX - Accelerate Diagnostics Inc Revenue Growth YoY (Last 12 Months)

Comparable year-over-year sales growth over 12 months demonstrates the effect of implementing hospital rapid diagnostic systems, which create sustainable B2B dependency. Revenues are based on the sale of equipment and consumable cartridges. Despite its leadership in sepsis detection, expansion requires significant investment. The value of -8.40 reflects the latest metric value, allowing for an assessment of the real dynamics of Accelerate Diagnostics (AXDX) operational inflows.

Accelerate Diagnostics Inc. (AXDX) Sales Growth YoY (Last Twelve Months): for the period 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for Accelerate Diagnostics, Inc. (AXDX)

- current quotes and average value forecast:

Stock Quotes Accelerate Diagnostics, Inc|AXDX - Analyst Consensus Forecast

- market capitalization statistics:

Market Valuation Accelerate Diagnostics, Inc.|AXDX - Enterprise Value

- shareholders' equity book value data:

Net Asset Value per Share Accelerate Diagnostics|AXDX - Company Book Value|Market Value to Book Value Ratio acceleratediagnostics.com|AXDX - Company Total Assets

- business debt structure and liquidity details:

Debt to Capital Accelerate Diagnostics|AXDX - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Accelerate Diagnostics, Inc.|AXDX - Company Aggregate Debts|Debts to Book Capitalization Accelerate Diagnostics, Inc|AXDX - Company Long-Term Liabilities|Amount of Current Liabilities Accelerate Diagnostics|Immediate Liquidity acceleratediagnostics.com

- earnings and market multiples details:

AXDX - Net Income|Expected Net Income Accelerate Diagnostics|AXDX - P/E Multiple|Price to Future Earnings Ratio Accelerate Diagnostics|AXDX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics, Inc.|AXDX - Operating profit EBITDA|Net earnings per share (EPS TTM) Accelerate Diagnostics|AXDX - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year acceleratediagnostics.com|AXDX - Earnings per share growth in current year|Projected earnings per share growth rate for next year Accelerate Diagnostics

- sales and revenue data:

AXDX - Company Revenue|Company Expected Sales Volume Accelerate Diagnostics Inc|AXDX - Price-to-Revenue Ratio|Market Cap to Expected Sales Ratio Accelerate Diagnostics, Inc|AXDX - Revenue Growth YoY (Last 12 Months)

Summary company analytics:AXDX (Accelerate Diagnostics)

Manufactured product of acceleratediagnostics.com

This indicator calculates the percentage change in total revenue over the last twelve months relative to the same period last year, neutralizing seasonal fluctuations and revealing the true vector of business expansion. For Accelerate Diagnostics (AXDX), the TTM revenue growth trajectory compared to last year confirms the monetization of high laboratory confidence in the accuracy of its diagnostic systems, transforming the brand's reputational stability into real financial scale.

Competitor analysis for Accelerate Diagnostics

Agilent Corp (A) - Trailing Twelve Months Revenue Growth|DGX - Sales Growth YoY (Last Twelve Months)|ILMN: Sales Growth YoY (Last Twelve Months)|EXAS: Sales Growth YoY (TTM)|RVTY (Revvity) - Sales Growth YoY (Last Twelve Months)|BIO (Bio-Rad Laboratories, Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Anbio Biotechnology NNNN|Revenue Growth YoY (Last 12 Months) SHC (Sotera Health Company)|Sales Growth YoY (Last Twelve Months) QDEL (quidel.com)|Sales Growth YoY (TTM) OPK (opko.com)|Revenue Dynamics YoY (Last Twelve Months) CDNA|MRVI: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) FLGT (Fulgent Corp)|LAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cytekbio.com (CTKB)|OSUR (OraSure Corp) - Sales Growth YoY (TTM)|Exagen (XGN) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Prenetics PRE|Insight Molecular (IMDX) - Trailing Twelve Months Revenue Growth|Trinity Biotech Corp - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) ProPhase PRPH|AIMD: Sales Growth YoY (TTM)|CODX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Heart Test Laboratories, Inc.|Sales Growth YoY (Last Twelve Months) BMRA|Sales Growth YoY (TTM) CDIO|Onconetix - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) viraxbiolabs.com VRAX|Annual Revenue Growth (Last Twelve Months) Bluejay (BJDX)|AWH: Revenue Growth YoY (Last 12 Months)|Revenue Growth Rate YoY (Last Twelve Months) Centogene NV (CNTG)|ENZ (Enzo Biochem) - Revenue Growth YoY (Last 12 Months)|fresh2.co (FRES) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Genetic Technologies Limited|Trailing Twelve Months Revenue Growth 23andMe Inc. ME|Sales Growth YoY (Last Twelve Months) Psychemedics (PMD)